STEENROD MITCHELL D
Known title: DirectorCIK: 0001511361
STEENROD MITCHELL D's purchase track record
STEENROD MITCHELL D has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 10/2/2025 | KMX | $91K | -14.7% | -10.5% | -2.0% |
| 4/24/2025 | KMX | $85K | -8.3% | -34.4% | +22.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Transaction History
| KMX | ▲ Buy | Open Market | 2,000 | $91K | 10/2/2025 | View on chart |
| KMX | ▲ Buy | Grant | 2,753 | $0 | 6/30/2025 | View on chart |
| KMX | ▲ Buy | Open Market | 1,300 | $85K | 4/24/2025 | View on chart |
| KMX | ▲ Buy | Grant | 2,598 | $0 | 7/1/2024 | View on chart |
| KMX | ▲ Buy | Grant | 2,210 | $0 | 6/30/2023 | View on chart |
| KMX | ▲ Buy | Grant | 1,996 | $0 | 7/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
CarMax Reports Earnings Turnaround Progress Amid Margin Pressure
CarMax reported earnings that show progress in its turnaround, with sales surging due to cost-cutting measures. However, the company faces ongoing margin pressure, which remains a challenge despite the positive revenue trends. Analysts have recently increased the consensus price target to $61.37, reflecting a mix of optimism about the cost savings and caution regarding profitability.
CarMax Reports Earnings Turnaround Progress Amid Margin Pressure. CarMax reported earnings that show progress in its turnaround, with sales surging due to cost-cutting measures. However, the company faces ongoing margin pressure, which remains a challenge despite the positive revenue trends. Analysts have recently increased the consensus price target to $61.37, reflecting a mix of optimism about the cost savings and caution regarding profitability.